In this short session, Robin Öz, CEO of VentriLabs, will provide a brief introduction to the company's novel pumping technology, designed for gentle and non-destructive handling of sensitive fluids in intensified bioprocesses and continuous perfusion applications. Robin will present data demonstrating the key benefits of VentriLabs' innovative technology, including improved cell viability and overall efficiency in bioprocessing.
